Prospective study evaluating the use of nasal glucagon for the treatment of moderate to severe hypoglycaemia in adults with type 1 diabetes in a real‐world setting

In the present multicentre, open‐label, prospective, phase III study, we evaluated the real‐world effectiveness and ease of use of nasal glucagon (NG) in the treatment of moderate/severe hypoglycaemic events (HEs) in adults with type 1 diabetes (T1D). Patients and caregivers were taught how to use N...

Descripción completa

Detalles Bibliográficos
Autores principales: Seaquist, Elizabeth R., Dulude, Hélène, Zhang, Xiaotian M., Rabasa‐Lhoret, Remi, Tsoukas, George M., Conway, James R., Weisnagel, Stanley J., Gerety, Gregg, Woo, Vincent C., Zhang, Shuyu, Carballo, Dolorès, Pradhan, Sheetal, Piché, Claude A., Guzman, Cristina B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2018
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947579/
https://www.ncbi.nlm.nih.gov/pubmed/29504662
http://dx.doi.org/10.1111/dom.13278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947579/
https://www.ncbi.nlm.nih.gov/pubmed/29504662
http://dx.doi.org/10.1111/dom.13278

Ejemplares similares